Glaukos (NYSE: GKOS) CDO reports tax-withholding of 1,074 shares – Stock Titan

SELLAS Life Sciences to Present Preclinical Data Highlighting Pot…
Faraday Future Announces Executive Share Purchase Initiative to S…
Coupang NVIDIA Collaboration on “AI Factory” Is Powering the Futu…
Ocean Power Technologies, Inc. Announces Third Quarter Fiscal 202…
Tonix Pharmaceuticals Announces Oral Presentation and Two Poster …
CytomX Therapeutics Announces Pricing of $250 Million Offering of…
SELLAS Life Sciences to Present Preclinical Data Highlighting Pot…
Faraday Future Announces Executive Share Purchase Initiative to S…
Coupang NVIDIA Collaboration on “AI Factory” Is Powering the Futu…
Ocean Power Technologies, Inc. Announces Third Quarter Fiscal 202…
Tonix Pharmaceuticals Announces Oral Presentation and Two Poster …
CytomX Therapeutics Announces Pricing of $250 Million Offering of…
Glaukos Corp chief development officer Tomas Navratil reported a tax-related share disposition. On March 13, 2026, 1,074 shares of common stock were withheld at $97.02 per share to satisfy tax withholding obligations tied to vesting restricted stock units.
After this tax-withholding disposition, Navratil directly holds 75,620 shares of common stock, which includes 38,456 restricted stock units that have not yet vested or been delivered.
Source: View Original Filing on SEC EDGAR
© 2020-2026 StockTitan.net – Your Edge is Information
Information only — not investment advice.

source
This is a newsfeed from leading technology publications. No additional editorial review has been performed before posting.